Merck KGaA submits EU application for Cladribine in RRMS: <a href="http://online.wsj.com/article/BT-CO-20090723-705752.html" rel="nofollow" target="_blank">http://online.wsj.com/article/BT-CO-20090723-705752.html</a> The U.S. NDA is expected to be submitted during the current calendar quarter.